HRT Financial’s Clearmind Medicine CMND Stock Holding History

HRT Financial’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77K	Buy	35,143 +33,552	+2,109%	+$191K	﹤0.01%	3677
2026 Q1	$16K	Buy	+1,591	New	+$24.6K	﹤0.01%	3592
2024 Q4	–	Sell	-32	Closed	-$15K	–	2526
2024 Q3	$15K	Buy	+32	New	+$18.2K	﹤0.01%	2209
2023 Q3	–	Sell	-1	Closed	-$8K	–	2472
2023 Q2	$8K	Buy	+1	New	+$6.75K	﹤0.01%	2186

Other funds holding CMND

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

HRT Financial's CMND Position: Q2 2026 in Review

HRT Financial increased its Clearmind Medicine (CMND) stake by 2,109% in Q2 2026, buying an estimated $191K and bringing the position to 35,143 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #3677.

HRT Financial first reported a position in CMND in Q2 2023 and has held it in 4 quarters since. 6 funds tracked by Wall St. Rank hold CMND as of Q2 2026.

HRT Financial held 35,143 shares of Clearmind Medicine worth $77K as of Q2 2026.
HRT Financial bought 33,552 Clearmind Medicine shares in Q2 2026, an estimated $191K.
Clearmind Medicine made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3677 holding.
HRT Financial first reported a position in Clearmind Medicine in Q2 2023 and has held it in 4 quarters since.
6 funds tracked by Wall St. Rank held Clearmind Medicine as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.